Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product -- Ignore unavailable to you. Want to Upgrade?

To: geewiz who wrote (320)	9/29/1998 7:35:00 PM
From: GREG FINLEY	Read Replies (2) \| Respond to of 534

Geewiz; Here is the transciption from ABC Nightly News you were inquiring about: abcnews.com They have a unique technology, although I don't think it is going to prove to be as affective in delivering vaccines as the Biojector 2000. They are in clinical trials now, so their technology is very speculative. They sure got some good press though, didn't they? My feeling is that BJCT is concentrating it's efforts on it's major corporate alliances and has pretty much discontinued it's attempts at making the public aware of their excellent, safe, drug delivery system. I'm think they are going to let their partners handle that part of it when appropriate. In the meantime, we continue to wait for positive news! Perhaps not too much longer. All the best, Greg